Join
Live feed
·
PRReleasevia Quantisnow
Zomedica Corp. logo

Zomedica Announces Preliminary 2023 Revenue; Provides Revenue Guidance for 2024, and Rationale for Share Consolidation ("Reverse Stock Split")

ByQuantisnow·Wall Street's wire, on your screen.
ZOM· Zomedica Corp.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ZOM (Zomedica Corp.) and more on Quantisnow.